“FDA Agrees to New Trials for Ecstasy as Relief for PTSD Patients”

0
Last week, the FDA gave permission for ecstasy to move into Phase 3 clinical trials for the treatment of PTSD. “If they can keep...

Rise in Psychiatric Prescriptions With NOS Diagnosis

11
A “not otherwise specified” (NOS) diagnosis is often used when an individual may have some symptoms related to a psychiatric diagnosis but does not meet enough criteria to warrant a particular diagnosis. A new study, published online ahead of print in Psychiatric Services, reveals that the proportion of mental health visits resulting in such NOS diagnoses rose to nearly fifty percent, and that these diagnoses do not result in more conservative psychiatric drug prescriptions.

The Psychedelic Renaissance is Here. Will it Last This Time?

4
From Massive: Increasing evidence suggests that psychedelics may revolutionize mental health care. In order for this "psychedelic renaissance" to last, scientists and citizens will need...

Top Psychiatrist Fired In “Political” Row Over PTSD-Marijuana Study

7
A psychiatrist at the University of Arizona was fired after state Republican Senators criticized her work to university officials, according to the New York...

“I Did Psychedelic First Aid at a Festival in Costa Rica”

1
-Eamon Armstrong describes the Zendo Project, and his own experience providing support for people taking psychedelic drugs.

“Flimsy Evidence” for Esketamine as Depression Treatment

9
A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

The Ketamine Consensus?

2
From Discover Magazine: A group of psychiatrists from the American Psychiatric Association has recently released A Consensus Statement on the Use of Ketamine in the...

‘Ego-Dissolving’ Psychedelic Drugs Could Improve Mental Health

0
From Medical Xpress: Researchers have proposed that psychedelic drugs such as LSD and magic mushrooms may help some people with anxiety, depression, and addiction by dissolving...

“FDA Forced to Release Adverse Event Reports on Psychiatric Drugs”

0
Following a lawsuit brought by Andrew Thibault of Parents Against Pharmaceutical Abuse (PAPA), the FDA has produced adverse event and severe adverse event reports...

“Scientists Push to Renew Psychedelic Drug Research for Psychiatry”

2
-CBC Radio interviews UK neuropsychopharmacologist David Nutt, Mark Haden of MAPS, and historian Erika Dyck about the past and present politics and science of psychedelic research.

Dissolving the Ego: Transcendence and Ecstasy

0
From Aeon: Experiencing ecstasy and transcendence has long been pathologized and marginalized by Western culture and the psychiatric model of "mental illness." However, ecstatic experiences, including...

British Psychiatrists Advocate Psychedelics for Depression

15
The journal Therapeutic Advances in Psychopharmacology has published a review of what is known about psychedelic drugs' biochemical effects in the human brain, their...

“Trust” In Therapeutic Relationship Key to Moderating Psychedelic Risks

2
-Psychiatry Advisor reports on psychiatrist James Rucker's campaign for more research into the therapeutic potentials of psychedelic drugs, and on critics who point to the risks.

Psychedelic Use Associated with Reductions in Suicidal Tendencies

36
People who have taken a psychedelic drug at least once have less suicidal thinking than the general population.

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

0
From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

“Can psychedelic trips cure PTSD and other maladies?”

1
The Washington Post explores some of the history of research into the therapeutic potentials of even just one session with a psychedelic drug, and...

“Warning Over Ketamine Use for Depression”

0
The Daily Telegraph reports on a warning published in the Medical Journal of Australia that urges doctors not to “jump the gun in prescribing patients the drug ketamine to treat depression.”

Can Psychedelics Help End Addictions with One Dose?

2
Q13 Fox News discusses recent research giving psychedelics to people struggling with alcohol or cigarettes. David Nutt, an Imperial College London neuro-psychopharmacologist "thinks psilocybin...

When Legal Drugs Harm and Illegal Drugs Help

0
From Scientific American: In a day and age when people are increasingly becoming addicted to prescription drugs, and increasingly helped by the therapeutic effects of illicit...

Despite “Flurry of Interest,” Ketamine Remains Unproven For Depression

22
In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

New Study Investigates Cannabidiol (CBD) for Psychosis

21
A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

Sunday Meditation: Are Non-ordinary States “Freeing” the Brain to Truly See?

2
On his blog Metaphysical Speculations, Bernardo Kastrup challenges conventional psychiatric assumptions that the brain produces and controls consciousness. Kastrup cites two recent studies published...

Sunday History Channel: Seventy-five Years of Psychedelic Psychiatry

3
Mo Costandi provides a brief history in The Guardian of research activities using psychedelic substances such as LSD for psychiatric and psychotherapeutic purposes. Costandi...

Researchers Find Inadequate Reporting of the Dangers of Ketamine Treatment for Depression

6
Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

What Is “Normal” Anyway?

1
From Scientific American: Although "normal" technically means average or typical, both researchers and the general public often view normality as a standard we should all...